X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Sterling Biotech with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STERLING BIOTECH vs ADCOCK INGRAM (S. Africa) - Comparison Results

STERLING BIOTECH    Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 STERLING BIOTECH   ADCOCK INGRAM
EQUITY SHARE DATA
    STERLING BIOTECH
Dec-13
ADCOCK INGRAM
Jun-14
STERLING BIOTECH/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs11357-   
Low Rs3258-   
Sales per share (Unadj.) Rs26.8106.3-  
Earnings per share (Unadj.) Rs-15.0-26.8-  
Cash flow per share (Unadj.) Rs-5.5-22.2-  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs54.983.5-  
Shares outstanding (eoy) m267.87168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.32.9 9.0%   
Avg P/E ratio x-0.5-11.5 4.0%  
P/CF ratio (eoy) x-1.3-13.9 9.2%  
Price / Book Value ratio x0.13.7 3.4%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,86251,922 3.6%   
No. of employees `0001.44.3 31.5%   
Total wages/salary Rs m5473,259 16.8%   
Avg. sales/employee Rs Th5,303.34,180.1 126.9%   
Avg. wages/employee Rs Th403.8759.1 53.2%   
Avg. net profit/employee Rs Th-2,959.0-1,053.3 280.9%   
INCOME DATA
Net Sales Rs m7,18117,945 40.0%  
Other income Rs m43126 33.9%   
Total revenues Rs m7,22318,071 40.0%   
Gross profit Rs m947-3,110 -30.4%  
Depreciation Rs m2,543775 328.4%   
Interest Rs m4,377486 900.5%   
Profit before tax Rs m-5,931-4,245 139.7%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,924265 -725.5%   
Profit after tax Rs m-4,007-4,522 88.6%  
Gross profit margin %13.2-17.3 -76.1%  
Effective tax rate %32.4-6.2 -519.3%   
Net profit margin %-55.8-25.2 221.4%  
BALANCE SHEET DATA
Current assets Rs m14,33513,143 109.1%   
Current liabilities Rs m49,8097,395 673.6%   
Net working cap to sales %-494.032.0 -1,542.2%  
Current ratio x0.31.8 16.2%  
Inventory Days Days403111 363.7%  
Debtors Days Days171124 137.7%  
Net fixed assets Rs m55,4327,661 723.5%   
Share capital Rs m26883 321.5%   
"Free" reserves Rs m13,9350-   
Net worth Rs m14,70114,085 104.4%   
Long term debt Rs m9,4784,950 191.5%   
Total assets Rs m73,98826,608 278.1%  
Interest coverage x-0.4-7.7 4.6%   
Debt to equity ratio x0.60.4 183.5%  
Sales to assets ratio x0.10.7 14.4%   
Return on assets %0.5-15.2 -3.3%  
Return on equity %-27.3-32.1 84.9%  
Return on capital %-6.4-19.8 32.4%  
Exports to sales %25.90-   
Imports to sales %0.20-   
Net fx Rs m1,8350-   
CASH FLOW
From Operations Rs m1,7191,532 112.2%  
From Investments Rs m-3,148-470 669.4%  
From Financial Activity Rs m1,4264,492 31.7%  
Net Cashflow Rs m-35,554 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.93 Rs / ZAR

Compare STERLING BIOTECH With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare STERLING BIOTECH With: GLENMARK PHARMA  CIPLA  AJANTA PHARMA  MERCK LTD  ABBOTT INDIA  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views On News

Galaxy Surfactants Ltd. (IPO)

Jan 27, 2018

Should you subscribe to the IPO of Galaxy Surfactants Ltd?

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STERLING BIOTECH SHARE PRICE


Sep 17, 2018 (Close)

TRACK STERLING BIOTECH

  • Track your investment in STERLING BIOTECH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STERLING BIOTECH

STERLING BIOTECH 8-QTR ANALYSIS

COMPARE STERLING BIOTECH WITH

MARKET STATS